McMillan Office’s Organon & Co OGN Stock Holding History

McMillan Office’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.9K	Hold	1,250	–	–	﹤0.01%	366
2026 Q1	$7.49K	Sell	1,250 -247	-16%	-$1.86K	﹤0.01%	406
2025 Q4	$10.7K	Buy	+1,497	New	+$11.8K	﹤0.01%	380

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

McMillan Office's OGN Position: Q2 2026 in Review

McMillan Office held its Organon & Co (OGN) position steady in Q2 2026 at 1,250 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #366.

McMillan Office first reported a position in OGN in Q4 2025 and has held it in 3 quarters since. 636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

McMillan Office held 1,250 shares of Organon & Co worth $16.9K as of Q2 2026.
McMillan Office left its Organon & Co share count unchanged in Q2 2026.
Organon & Co made up ﹤0.01% of McMillan Office's portfolio in Q2 2026, its #366 holding.
McMillan Office first reported a position in Organon & Co in Q4 2025 and has held it in 3 quarters since.
636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.